BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2783065)

  • 1. Posterior vitreous fluorophotometry. I. Description of a new analysis procedure and results in normal subjects.
    Bungay PM; Roy MS; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1321-7. PubMed ID: 2783065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
    Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
    Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.
    Blair NP; Rusin MM
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(5):419-22. PubMed ID: 3093315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP; Zeimer RC; Rusin MM; Cunha-Vaz JG
    Arch Ophthalmol; 1983 Jul; 101(7):1117-21. PubMed ID: 6870634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the blood-retinal barrier and vitreous in sickle cell retinopathy.
    Paylor RR; Carney MD; Ogura Y; Cunha-Vaz JG; Jampol LM; Goldberg MF
    Int Ophthalmol; 1986 May; 9(2-3):103-8. PubMed ID: 3721713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystalline retinopathy: evaluation of blood-retinal barrier by vitreous fluorophotometry.
    Yoshida A; Nara Y; Takahashi M
    Jpn J Ophthalmol; 1985; 29(3):290-300. PubMed ID: 4079126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of vitreous fluorophotometry in patients with type 1 diabetes mellitus.
    Jager J; Tromp A; Hooymans JM; Reitsma WD; Smit AJ
    Ophthalmologica; 1997; 211(4):209-13. PubMed ID: 9216008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of fluorescein in the ocular posterior segment in retinitis pigmentosa.
    Mallick KS; Zeimer RC; Fishman GA; Blair NP; Anderson RJ
    Arch Ophthalmol; 1984 May; 102(5):691-6. PubMed ID: 6721754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB.
    Moldow B; Sander B; Larsen M; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1770-5. PubMed ID: 10393047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of fluorescein to vitreous in vitro.
    Knudsen LL
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):352-7. PubMed ID: 3618161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interpretation of vitreous fluorophotometry.
    Zeimer RC; Blair NP; Cunha-Vaz JG
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1374-81. PubMed ID: 6618797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.